πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 255 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10520517

Disease severity index for assessment of chronic liver disease

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10512687

Compositions and methods for enhanced innate immunity

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10512672

Methods for the treatment of inflammatory joint disease

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10508122

Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetyla

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10488416

Targeting breast cancer therapy based on stromal subtypes and CD146 composition

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10478508

Compositions, methods and uses for alpha-1 antitrypsin fusion molecules

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10456448

PTD-SMAD7 therapeutics

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10428082

Triazole derivatives of melampomagnolide B and methods of use thereof

The Regents of the University of Colorado, a body Β· Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10428126

Dermaseptin-type and piscidin-type antimicrobial peptides

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10420813

Competitive inhibitors of invariant chain expression and/or ectopic clip binding

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10413603

Compositions, methods and uses for improved human papilloma virus constructs

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10413620

Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10407484

Compositions and methods for modulating T-cell mediated immune response

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10406214

Propionyl-CoA carboxylase compositions and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10383939

Light-activated compositions and methods using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10363288

Insulin mimotopes and methods of using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10350265

Therapeutic applications of Smad7

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10307437

Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotid

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10300107

Compositions and methods for CaMKII inhibitors and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10278986

Antibody-siRNA conjugates and uses therefor

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10280415

Human cystathionine Ξ²-synthase variants and methods of production thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10265387

Compositions and methods for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10258606

Endothelin single nucleotide polymorphisms and methods of predicting Ξ²-adrenergic receptor

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10253024

Polycyclic indoline and indolenine compounds

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted